AbbVie (ABBV) EBIT (2012 - 2026)
AbbVie (ABBV) recorded EBIT of $6.27 billion in Q3 2026, up 229.1% from $1.9 billion a year earlier but down 2.6% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) EBIT (2012 - 2026) Analysis & Trends
On a TTM basis, AbbVie's EBIT came in at $21.23 billion as of Sep 30, 2026, up 134.9% year-over-year; for FY2025, it was $15.08 billion, up 65.0% from FY2024.
- Annual EBIT has a five-year compound annual growth rate of 5.8% (FY2020 to FY2025).
- Across earlier years, EBIT came in at $9.14 billion in FY2024 (-28.4%), $12.76 billion in FY2023 (-29.6%), $18.12 billion in FY2022 (+1.1%) and $17.92 billion in FY2021 (+57.7%).
- Quarterly EBIT has ranged from -$1.49 billion in Q4 2024 to $6.43 billion in Q2 2026 over the past five years.
- On a year-over-year basis, EBIT has increased for three consecutive quarters, with growth averaging 45.5% over the last six quarters.
- Peak year-over-year performance for EBIT in the last five years was growth of 229.1% in Q3 2026, against a decline of 50.4% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.43 billion (Q2 2026), $3.99 billion (Q1 2026) and $4.54 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 12.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 5.59 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 712.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.27 Bn |
| Jun 30, 2026 | 6.43 Bn |
| Mar 31, 2026 | 3.99 Bn |
| Dec 31, 2025 | 4.54 Bn |
| Sep 30, 2025 | 1.90 Bn |
| Jun 30, 2025 | 4.89 Bn |
| Mar 31, 2025 | 3.73 Bn |
| Dec 31, 2024 | -1.49 Bn |
| Sep 30, 2024 | 3.83 Bn |
| Jun 30, 2024 | 4.00 Bn |
| Mar 31, 2024 | 2.80 Bn |
| Dec 31, 2023 | 3.20 Bn |
| Sep 30, 2023 | 2.28 Bn |
| Jun 30, 2023 | 4.51 Bn |
| Mar 31, 2023 | 2.77 Bn |
| Dec 31, 2022 | 5.50 Bn |
| Sep 30, 2022 | 4.60 Bn |
| Jun 30, 2022 | 3.30 Bn |
| Mar 31, 2022 | 4.72 Bn |
| Dec 31, 2021 | 5.07 Bn |
API Access
AbbVie EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();